Clinical Trials Logo

Clinical Trial Summary

The study will evaluate the effect of activated charcoal on absorption of LY2140023. The study involves a single dose of 80 milligrams (mg) LY2140023 taken as 1 tablet by mouth 2 times during study (once with activated charcoal, once without activated charcoal). This study will last approximately 16 days, not including screening. Screening is required within 28 days prior to study entry.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01609218
Study type Interventional
Source Denovo Biopharma LLC
Contact
Status Completed
Phase Phase 1
Start date June 2012
Completion date September 2012

See also
  Status Clinical Trial Phase
Completed NCT03270878 - Glasdegib Absolute Bioavailability Study Phase 1
Completed NCT03777488 - Pharmacokinetics of Tranexamic Acid After Oral, Intramuscular or Intravenous Administration: a Prospective, Randomised, Cross-over Trial in Healthy Volunteers. Phase 1
Completed NCT03086278 - A Study of AST-008 in Healthy Subjects Phase 1
Completed NCT04711187 - Study of AT-527 in Healthy Subjects (R07496998) Phase 1
Completed NCT06141889 - Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers Phase 1
Completed NCT05154123 - Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998) Phase 1
Completed NCT05179421 - Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain Phase 2
Completed NCT03945344 - Effect of Charcoal on Gastrointestinal Absorption of Tiotropium Phase 1
Recruiting NCT05881993 - Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects Early Phase 1
Completed NCT04242953 - Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects Phase 1
Completed NCT02393950 - Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers Phase 1
Completed NCT00866385 - AZD8566 Food Effect/Microtracer Study Phase 1
Completed NCT04784000 - Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527 Phase 1
Completed NCT02503085 - Ibuprofen Suspension Bioequivalence Study Phase 1
Completed NCT05004415 - Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998) Phase 1
Completed NCT02256423 - A Study Comparing Three Formulations of Ibuprofen in Healthy Subjects Phase 1
Completed NCT01425450 - Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers Phase 1
Completed NCT05731843 - Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir Phase 1
Completed NCT03031535 - Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers Phase 1
Completed NCT02452450 - Ibuprofen and Paracetamol Pharmacokinetic Study Phase 1